CLINICAL_TRIALS
withdrawal
· 2021-09-28
Clinical Trial Update: Multimodal Analgesia in Shoulder Arthroplasty [Phase 3]
Summary
Phase 3 trial on multimodal analgesia for shoulder arthroplasty was withdrawn from development.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Rush University Medical Center | Conditions: Shoulder Pain, Opioid Use | Phase 3 | Status: WITHDRAWN